Fast Start for FDA Drug Approvals in 2017
By Michael Mezher -
Published 12 April 2017
The US Food and Drug Administration (FDA) is poised to make a comeback from the relatively low number of new drugs approved in 2016, though it's unlikely to match the approval highs from 2014 and 2015.
Categories: News, US, FDA, Biologics and biotechnology, Drugs, Submission and registration
Tags: Approvals, New Molecular Entities, Biologics License Applications
How Many Drugs has FDA Approved in its Entire History? New Paper Explains
By Alexander Gaffney, RAC -
Published 03 October 2014
Pop quiz: While the US Food and Drug Administration (FDA) approves dozens of drugs each year, how many new drugs—i.e. discounting generic versions of approved drugs—has it approved in its entire existence?
Categories: Biologics and biotechnology, Drugs, Regulatory intelligence
Tags: FDA NME Approvals, New Molecular Entities, Drug Approvals, FDA Drug Approvals